{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "An alarmingly high number of women with heart disease are failing to take medicines known to reduce their risks of heart attacks, according to a study released yesterday. The study, published in The Annals of Internal Medicine, found that although at least 85 percent of the 2,763 women studied should have been taking drugs to lower cholesterol, just about half did so.", "headline": {"main": "Many Women Skip the Aspirin", "kicker": "VITAL SIGNS: PREVENTION"}, "abstract": "New study finds alarmingly high number of postmenopausal women with heart disease are failing to take medicines known to reduce their risks of heart attacks; finds that at least 85 percent of women studied should have been taking drugs to lower cholesterol, but only half did so; finds virtually all should have been taking preventive doses of aspirin, but only 83 percent did; finds women at highest risk were least likely to use drugs (S)", "print_page": "6", "word_count": 260, "_id": "4fd227d38eb7c8105d7b0e4c", "snippet": "An alarmingly high number of women with heart disease are failing to take medicines known to reduce their risks of heart attacks, according to a study released yesterday.    The study, published in The Annals of Internal Medicine, found that although...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/01/21/health/vital-signs-prevention-many-women-skip-the-aspirin.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "O'NEIL, JOHN"}, {"name": "subject", "value": "HEART"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "WOMEN"}, {"name": "subject", "value": "ASPIRIN"}, {"name": "subject", "value": "CHOLESTEROL"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "John", "lastname": "O'NEAL"}], "original": "By JOHN O'NEAL"}, "document_type": "article", "pub_date": "2003-01-21T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "To slow the growth of Medicare, an influential federal advisory panel will soon recommend that Congress freeze payments to nursing homes and home care agencies and reduce the cost-of-living allowance that hospitals are scheduled to receive next year. Republicans in Congress and Bush administration officials welcomed the proposals, saying they would save money for taxpayers and the Medicare trust fund. But health care providers expressed alarm, saying the proposals could reduce access to care for millions of the elderly and disabled.", "headline": {"main": "Commission to Urge Freezing Some Medicare Payments"}, "abstract": "Medicare Payment Advisory Commission, influential federal advisory panel, will recommend that Congress freeze payments to nursing homes and home care agencies and reduce cost-of-living allowance that hospitals are scheduled to receive next year, in order to slow growth of Medicare; Republicans in Congress and Bush administration officials welcome proposals, saying they would save money for taxpayers and Medicare trust fund; health care providers express alarm; panel will also recommend 2.5 percent increase in Medicare payments to doctors next year; payments to doctors were cut 5.4 percent last year, and futher cut of 4.4 percent is scheduled to take effect Mar 1; regarding proposed freeze on payments to nursing homes and home care agencies, many of 17 commissioners on panel say Medicare has no obligation to make up for underpayments by other insurers, like Medicaid (M)", "print_page": "18", "word_count": 862, "_id": "4fd227d08eb7c8105d7b0b61", "snippet": "To slow the growth of Medicare, an influential federal advisory panel will soon recommend that Congress freeze payments to nursing homes and home care agencies and reduce the cost-of-living allowance that hospitals are scheduled to receive next year....", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/01/19/us/commission-to-urge-freezing-some-medicare-payments.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "organizations", "value": "MEDICARE PAYMENT ADVISORY COMMISSION"}, {"name": "subject", "value": "MEDICAID"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "HOSPITALS"}, {"name": "subject", "value": "NURSING HOMES"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2003-01-19T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Money and Business/Financial Desk", "lead_paragraph": "THE printed advertisement showed water gushing through an opening in a dam. ''It could feel like this again,'' the accompanying text said. Puzzled? You probably wouldn't be if you knew where the ad appeared: in the men's restrooms of 100 or so restaurants in Minneapolis and St. Paul last year. The ads, sponsored by Medtronic, the medical device manufacturer, promoted a minimally invasive procedure that can be administered by a urologist to help relieve urinary discomfort from an enlarged prostate. The company, based in Minneapolis, also ran ads in the women's restrooms at the same restaurants, promoting an implantable device to relieve incontinence. These ads had an empowerment theme: ''Bladder control problems shouldn't control your life. You should.''", "headline": {"main": "Risky Turn on Madison Avenue", "kicker": "MONEY & MEDICINE"}, "abstract": "Debate on advisability of current spate of direct-to-consumer medical device advertisements discussed; Medtronic's advertising in public restrooms of devices to control incontinence cited; drawing (M)", "print_page": "9", "word_count": 898, "_id": "4fd227d08eb7c8105d7b0b6a", "snippet": "THE printed advertisement showed water gushing through an opening in a dam. ''It could feel like this again,'' the accompanying text said. Puzzled? You probably wouldn't be if you knew where the ad appeared: in the men's restrooms of 100 or so...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/01/19/business/money-medicine-risky-turn-on-madison-avenue.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "MEDTRONIC INC"}, {"name": "subject", "value": "ADVERTISING"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "INCONTINENCE"}, {"name": "subject", "value": "BATHROOMS AND TOILETS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Michelle", "lastname": "ANDREWS"}], "original": "By MICHELLE ANDREWS"}, "document_type": "article", "pub_date": "2003-01-19T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The numbers have been inching down for decades, but only lately have doctors begun to appreciate how profoundly things have changed for heart attacks and strokes. They remain the leading cause of death in the United States, but their toll is nothing like what it used to be. They kill proportionately fewer people and -- in another major change -- they strike far later in life. Despite the obesity epidemic, the trends are continuing with no end in sight.", "headline": {"main": "Gains on Heart Disease Leave More Survivors, and Questions"}, "abstract": "Heart attacks and strokes remain leading cause of death in United States, but they are killing proportionately fewer people and striking far later in life; statisticians at National Heart, Lung and Blood Institute calculate that if death rates were same as those of 30 years ago, 815,000 more Americans a year would be dying of heart disease and 250,000 more of strokes; instead, typical patient today is man or women of 70 or older, who survives; Dr Eugene Braunwald of Harvard Medical School calls reductions in death rates from heart attack and stroke one of great triumphs of medicine in past 50 years; downside of this triumph is that althouth many more men or women in their 70's and 80's are surviving heart attacks, they are left with severe heart disease; Braunwald notes that heart disease has been converted from acute illness to chronic disease; heart attack survivors often develop congestive heart failure, while life after stroke can include dementia and nursing homes and increasing disability; some in medical profession wonder whether extension of life, if it is accompanied by frailty and dementia, is such a good development; plunging death rates have come about because of new drugs, new treatments and changes in behavior; graph (M)", "print_page": "1", "word_count": 1358, "_id": "4fd26cea8eb7c8105d825e8d", "snippet": "The numbers have been inching down for decades, but only lately have doctors begun to appreciate how profoundly things have changed for heart attacks and strokes.    They remain the leading cause of death in the United States, but their toll is...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/01/19/us/gains-on-heart-disease-leave-more-survivors-and-questions.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BRAUNWALD, EUGENE"}, {"name": "organizations", "value": "NATIONAL HEART, LUNG AND BLOOD INSTITUTE"}, {"name": "subject", "value": "HEART"}, {"name": "subject", "value": "AGE, CHRONOLOGICAL"}, {"name": "subject", "value": "STROKE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "2003-01-19T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Johnson & Johnson has agreed to acquire 3-Dimensional Pharmaceuticals for about $88 million, the companies said yesterday. Johnson & Johnson will pay $5.74 a share for 3-Dimensional, an 89 percent premium to the shares' close of $3.03 on Wednesday. The transaction is unlikely to have a material effect on Johnson & Johnson's revenue or earnings, the companies said. 3-Dimensional, based in Yardley, Pa., uses a combination of chemistry, molecule screening and drug structure design to develop drugs in the areas of cancer, inflammation, metabolic and cardiovascular disease.", "headline": {"main": "JOHNSON & JOHNSON IS BUYING DRUG MAKER FOR $88 MILLION", "kicker": "COMPANY NEWS"}, "abstract": "Johnson & Johnson agrees to acquire 3-Dimensional Pharmaceuticals for about $88 million (S)", "print_page": "4", "word_count": 89, "_id": "4fd23f668eb7c8105d7d6a72", "snippet": "Johnson & Johnson has agreed to acquire 3-Dimensional Pharmaceuticals for about $88 million, the companies said yesterday. Johnson & Johnson will pay $5.74 a share for 3-Dimensional, an 89 percent premium to the shares' close of $3.03 on Wednesday....", "source": "Reuters", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/01/17/business/company-news-johnson-johnson-is-buying-drug-maker-for-88-million.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "JOHNSON & JOHNSON INC"}, {"name": "organizations", "value": "THREE-DIMENSIONAL PHARMACEUTICALS INC"}, {"name": "subject", "value": "MERGERS, ACQUISITIONS AND DIVESTITURES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": null, "document_type": "article", "pub_date": "2003-01-17T00:00:00Z", "section_name": "Business"}], "meta": {"hits": 5, "offset": 0, "time": 124}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}